期刊文献+

胰岛素样生长因子1受体和血管内皮生长因子C表达及其与宫颈癌淋巴结转移的关系 被引量:3

The expression of IGF-1R,VEGF-C and its relationship with cervical cancer lymph node metastasis
原文传递
导出
摘要 目的研究宫颈癌中胰岛素样生长因子1受体(IGF-1R)和血管内皮生长因子C(VEGF-C)的表达及其与淋巴结转移关系。方法选取河南科技大学第一附属医院2008年9月至2011年5月50例宫颈鳞癌组织为研究组,30例正常宫颈组织为对照组,应用SP免疫组化法研究IGF-1R、VEGF-C的表达情况。结果研究组淋巴结转移与IGF-1R、VEGF-C阳性表达有关(P<0.05)。D2-40标记的淋巴管密度(LVD)在IGF-1R、VEGF-C阳性表达组明显高于阴性组,且两者的阳性表达在研究组呈正相关。结论 IGF-1R、VEGF-C的表达与宫颈癌的淋巴转移有关,对于早期判断淋巴结转移有一定价值,联合检测二者有助于判断预后,指导临床治疗。 Objective Explore the expression of IGF-1 R, VEGF-C and its relationship with cervical cancer lymph node metastasis. Methods Selected 50 cases of cervical squamous carcinoma tissues as the experimental group, 30 cases of normal cervical tissue as control group, using immunohistochemical SP method research the expression of IGF-1R, VEGF-C. Results The experimental group, lymph node metastasis was the positive expression of IGF-1R and VEGF-C (P 〈 0. 05 ). Lymphatic vessel density marked by D2-40 in IGF-1R, VEGF-C positive expression group was significantly higher than negative group, and both positive expression in the experimental group were positively correlated. Conclusion The expression of IGF-I R, VEGF-C associated with cervical lymph node metastasis, lymphatic channel transfer has certain value for early judgment of cervical squamous carcinoma, joint detection both are important indicator of prognosis, and could guide clinical treatment.
出处 《中国实用妇科与产科杂志》 CAS CSCD 北大核心 2014年第6期437-440,共4页 Chinese Journal of Practical Gynecology and Obstetrics
关键词 宫颈鳞癌 免疫组织化学 胰岛素样生长因子1受体 血管内皮生长因子C cervical squamoas cell carcinoma immunohistochemical IGF-1 R VEGF-C
  • 相关文献

参考文献9

  • 1Novosyadlyy R, Vijayakumar A, Lann D, et al. Physical and functional interaction between polyoma virus middle T antigen and insulin and IGF-1 R is required for oncogene activation and tumor initiation [ J ]. Oncogene ,2009,28 ( 39 ) :3477-3486.
  • 2Seccareccia E, Brodt P. The role of the insulin-like growth factor- 1 receptor in malignancy: an update [ J]. Growth Horm IGF Res,2012,22(6) :193-199.
  • 3Yerushalmi R,Gelmon KA , Leung S, et ah Insulin-like growth factor receptor ( IGF-I R) in breast cancer subtypes[ J]. Breast Cancer Res Treat, 2012,132 : 131-142.
  • 4Ji RC. Lymphatic endothelial cells, lymphangiogenesis, and ex-tracellular matrix [ J ]. Lymph Res Biol, 2006,4 ( 2 ) : 83 -100.
  • 5Chekhonin VP,Shein SA,Korchagina A A, et al. VEGF in tumor progression and targeted therapy [ J ]. Curr Cancer Drug Tar- gets,2013,13 (4) :423-443.
  • 6Wang Z,Chen , Li X,et al. Expression of VEGF-C/VEGFR-3 in human laryngeal squamous cell carcinomas and its signifi- cance for lymphatic metastasis [ J]. Asian Pac J Cancer Prey, 2012,13(1 ) :27-31.
  • 7Kawakami M, Yanai Y, Hala F, et aL Vascular endothelial Growth factor C promotes lymph node metastasis in a rectal cancer orthotopic model [ J ]. Surg Today, 2005,35 ( 2 ) : 131 - 138.
  • 8张梅娟,张丽华.免疫标记物D2-40在病理诊断中的应用和意义[J].诊断学理论与实践,2007,6(3):277-280. 被引量:20
  • 9Tang Y, Zhang D, Fallavollita L, et al. Vascular endothelial growth factor C expression and lymph node matastasis are regu- lated by the type I insulin-like growth factor receptor [ J]. Cancer Res,2003,63(6) :1161-1171.

二级参考文献23

  • 1金钢,胡先贵,刘瑞,张怡杰,邵成浩,唐岩.胰腺癌组织淋巴管分布及密度的临床病理学[J].中国医学科学院学报,2005,27(5):583-586. 被引量:12
  • 2[1]Marks A,Sutherland DR,Bailey D,et al.Characterization and distribution of an oncofetal antigen(M2A antigen)expressed on testicular germ cell tumours[J].Br J Cancer,1999,80(3-4):569-578.
  • 3[2]Schacht V,Dadras SS,Johnson LA,et al.Up-regulation of the lymphatic marker podoplanin,a mucin-type transmembrane glycoprotein,in human squamous cell carcinomas and germ cell tumors[J].Am J Pathol,2005,166(3):913-921.
  • 4[3]Kaiserling E.Immunohistochemical identification of lymph vessels with D2-40 in diagnostic pathology[J].Pathologe,2004,25(5):362-374.
  • 5[4]Nakamura Y,Kanemura Y,Yamada T,et al.D2-40 antibody immunoreactivity in developing human brain,brain tumors and cultured neural cells[J].Mod Pathol,2006,19(7):974-985.
  • 6[5]Roy S,Chu A,Trojanowski JQ,et al.D2-40,a novel monoclonal antibody against the M2A antigen as a marker to distinguish hemangioblastomas from renal cell carcinomas[J].Acta Neuropathol(Berl),2005,109(5):497-502.
  • 7[6]Muller AM,Franke FE,Muller KM.D2-40:a reliable marker in the diagnosis of pleural mesothelioma[J].Pathobiology,2006,73(1):50-54.
  • 8[7]Chu AY,Litzky LA,Pasha TL,et al.Utility of D2-40,a novel mesothelial marker,in the diagnosis of malignant mesothelioma[J].Mod Pathol,2005,18(1):105-110.
  • 9[8]Bassarova AV,Nesland JM,Davidson B.D2-40 is not a specific marker for cells of mesothelial origin in serous effusions[J].Am J Surg Pathol,2006,30(7):878-882.
  • 10[9]Liang H,Giorgadze R,Bellucci K,et al.D2-40 is highly expressed in primary skin adnexal carcinomas but negative in adenocarcinoma metastases to skin[J].Mod Pathol,2005,18:86A-86A 386 Suppl.

共引文献19

同被引文献20

引证文献3

二级引证文献18

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部